- Title: Subtitle
- Clinical Outcomes in Patients with Mantle Cell Lymphoma Who Received Autologous Stem Cell Transplant in the Second Line Setting
- Creators
- Jennifer Jane Gile - 1Mayo Clinic, Rochester, MNAllison M. Bock - Mayo ClinicReema K. Tawfiq - 1Mayo Clinic, Rochester, MNMelissa C. Larson - Mayo ClinicKittika Poonsombudlert - University of IowaSeth M. Maliske - University of IowaMatthew J. Maurer - Mayo ClinicJames R. Cerhan - Mayo ClinicBrian Kabat - Mayo ClinicBrianna Gysbers - Mayo ClinicKatherine Smith - Mayo ClinicSteven R Hwang - Mayo ClinicDavid J. Inwards - Mayo ClinicJonas Paludo - Mayo ClinicStephen M. Ansell - Mayo ClinicThomas M. Habermann - Mayo ClinicSabarish Ayyappan - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteThomas E. Witzig - Mayo ClinicGrzegorz S. Nowakowski - Mayo ClinicUmar Farooq - University of IowaYucai Wang - Mayo Clinic
- Resource Type
- Abstract
- Publication Details
- Blood, Vol.140(Supplement 1), pp.6517-6519
- DOI
- 10.1182/blood-2022-165419
- ISSN
- 0006-4971
- eISSN
- 1528-0020
- Language
- English
- Date published
- 11/15/2022
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Internal Medicine
- Record Identifier
- 9984362344502771
Abstract
Clinical Outcomes in Patients with Mantle Cell Lymphoma Who Received Autologous Stem Cell Transplant in the Second Line Setting
Blood, Vol.140(Supplement 1), pp.6517-6519
11/15/2022
DOI: 10.1182/blood-2022-165419
Details
Metrics
34 Record Views